CP and hematologic disorder: This premise was corroborated by an observational study in immunocompromised patients who had a solid organ or hematologic transplant, or active hematologic malignancy, presenting no detectable IgG against SARS-CoV-2 pre-CP; however, CP increased their antibody levels and offered positive outcomes based on the WHO recovery scale [36].